.png){kind=icon}
Return
Viral gastroenteritis
.png){kind=icon}
PRE
AI
DOI：10.1016/S0140-6736(23)02037-8.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Since the discovery of norovirus in 1972 as a cause of what was contemporarily known as acute infectious nonbacterial gastroenteritis, scientific understanding of the viral gastroenteritides has continued to evolve. It is now recognised that a small number of viruses are the predominant cause of acute gastroenteritis worldwide, in both high-income and low-income settings. Although treatment is still largely restricted to the replacement of fluid and electrolytes, improved diagnostics have allowed attribution of illness, enabling both targeted treatment of individual patients and prioritisation of interventions for populations worldwide. Questions remain regarding specific genetic and immunological factors underlying host susceptibility, and the optimal clinical management of patients who are susceptible to severe or prolonged manifestations of disease. Meanwhile, the worldwide implementation of rotavirus vaccines has led to substantial reductions in morbidity and mortality, and spurred interest in vaccine development to diminish the impact of the most prevalent viruses that are implicated in this syndrome.
Keywords:
HUMAN ROTAVIRUS VACCINE
HUMAN INTESTINAL ENTEROIDS
NOROVIRUS INFECTION
DOUBLE-BLIND
ADENOVIRUS INFECTIONS
BIRTH COHORT
RISK-FACTOR
CHILDREN
DIARRHEA
DISEASE
Journal
IF:
88.5
Papers:
5.4W
Citations:
34.8W
Organization
Cited Papers
ShareSaveEpidemiology of Classic and Novel Human Astrovirus: Gastroenteritis and Beyond.png)
VIRUSES-BASEL
OAAI
VIRUSES-BASELIF3.5
OAAIShareSaveEffect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trialLANCET
LANCETIF88.5
PREAI
ShareSaveShareSaveHuman adenovirus infections in pediatric population - An update on clinico-pathologic correlationBIOMEDICAL JOURNAL
OAAI
BIOMEDICAL JOURNALIF4.4
OAAIShareSave
View more